[1] BARTEL D P.MicroRNAs:genomics, biogenesis, mechanism, and function[J].Cell, 2004, 116(2):281-297. [2] RIVERA-BARAHONA A, PEREZ B, RICHARD E, et al. Role of miRNAs in human disease and inborn errors of metabolism[J]. J Inherit Metab Dis, 2017, 40(4):471-480. [3] VIENBERG S, GEIGER J, MADSEN S, et al. MicroRNAs in metabolism[J]. Acta Physiol (Oxf), 2017, 219(2):346-361. [4] HUANG T, SHE K, PENG G, et al. MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer[J]. Int J Oncol, 2016, 49(4):1437-1444. [5] ZHAO X, WANG Y, DENG R, et al. miR186 suppresses prostate cancer progression by targeting Twist1[J]. Oncotarget, 2016, 7(22):33136-33151. [6] HE W, FENG J, ZHANG Y, et al. microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2[J]. Lab Invest, 2016, 96(3):317-324. [7] SUN K X, JIAO J W, CHEN S, et al. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1[J]. J Ovarian Res, 2015, 8(1):80-87. [8] JIANG JM, MO HL, LIU C, et al. Inhibition of miR-186-5p contributes to high glucose-induced injury in AC16 cardiomyocytes[J]. Exp Ther Med, 2018, 15(1):627-632. [9] KIM J, YOON H, CHUNG D E, et al. miR-186 is decreased in aged brain and suppresses BACE1 expression[J]. J Neurochem, 2016, 137(3):436-445. [10] BOSTJANCIC E, ZIDAR N, GLAVAC D. MicroRNA microarray expression profiling in human myocardial infarction[J]. Dis Markers, 2009, 27(6):255-268. [11] LIVAK K J, SCHMITTGEN T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4):402-408. [12] GIMBRONE M A, GARCIA-CARDENA G. Endothelial cell dysfunction and the pathobiology of atherosclerosis[J]. Circ Res, 2016, 118(4):620-636. [13] SMALL E M, OLSON E N. Pervasive roles of microRNAs in cardiovascular biology[J]. Nature, 2011, 469(7330):336-342. [14] SCHOBER A, NAZARI-JAHANTIGH M, WEI YY, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1[J]. Nat Med, 2014, 20(4):368-376. [15] CANFRÁN-DUQUE A, ROTLLAN N, ZHANG X, et al. Macrophage deficiency of miR-21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis[J]. EMBO Mol Med, 2017, 9(9):1244-1262. [16] ZHAO J, OU S L, WANG W Y, et al. MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2[J]. Am J Transl Res, 2017, 9(7):3433-3442. [17] XU KC, LIU P, ZHAO Y. Upregulation of microRNA-876 induces endothelial cell apoptosis by suppressing Bcl-Ⅺ in development of atherosclerosis[J]. Cell Physiol Biochem, 2017, 42(4):1540-1549. [18] WANG K J, ZHAO X, LIU Y Z, et al. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction[J]. Cell Physiol Biochem, 2016, 38(3):1015-1029. [19] ZELLER T, KELLER T, OJEDA F, et al. Assessment of microRNAs in patients with unstable angina pectoris[J].Eur Heart J, 2014, 35(31):2106-2114. [20] WU J, SONG J, WANG C, et al. Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects[J]. Int J Cardiol, 2014, 172(1):232-234. [21] YAO Y, ZHANG X, CHEN H P, et al. MicroRNA-186 promotes macrophage lipid accumulation and secretion of pro-inflammatory cytokines by targeting cystathionine gamma-lyase in THP-1 macrophages[J]. Atherosclerosis, 2016, 250:122-132. [22] DANG R Y, LIU F L, LI Y. Circular RNA hsa_circ_0010729 regulates vascular endothelial cell proliferation and apoptosis by targeting the miR-186/HIF-1alpha axis[J]. Biochem Biophys Res Commun, 2017, 490(2):104-110. [23] WU RZ, SHEN DP, SOHUN H, et al. miR186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease[J]. Int J Mol Med, 2018, 41(4):1899-1908. [24] EBERT M S, NEILSON J R, SHARP P A. MicroRNA sponges:competitive inhibitors of small RNAs in mammalian cells[J]. Nature Methods, 2007, 4(9):721-726. [25] NASRI M, KARIMI A, ALLAHBAKHSHIAN FARSANI M. Production, purification and titration of a lentivirus-based vector for gene delivery purposes[J]. Cytotechnology, 2014, 66(6):1031-1038. |